In the last 12 months, insiders at Silo Pharma, Inc. ($SILO) filed 21 transactions with the SEC: 16 open-market purchases totaling $34,942 and 0 sales totaling $0. Net insider sentiment: net buying.
Silo Pharma, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Weisblum Eric (CEO and President) — 9 transactions totaling $22,955
- Weisblum Eric (Chief Executive Officer) — 8 transactions totaling $11,986
- Pavell Jeff (Director) — 1 transaction totaling $0
- Ryweck Daniel E. (Chief Financial Officer) — 1 transaction totaling $0
- Munoz Kevin (Director) — 1 transaction totaling $0
View all SEC Filings for Silo Pharma, Inc. (SILO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2025 | Weisblum Eric | Chief Executive Officer | P | Common Stock | 2500 | $0.42 | 216,932.0000 | 9,331,346 | 1.17% | 0.03% |
| Dec. 15, 2025 | Weisblum Eric | Chief Executive Officer | P | Common Stock | 2500 | $0.41 | 214,432.0000 | 9,331,346 | 1.18% | 0.03% |
| Nov. 21, 2025 | Weisblum Eric | Chief Executive Officer | P | Common Stock | 1000 | $0.37 | 211,932.0000 | 9,331,346 | 0.47% | 0.01% |
| Nov. 20, 2025 | Weisblum Eric | Chief Executive Officer | P | Common Stock | 1000 | $0.37 | 210,932.0000 | 9,331,346 | 0.48% | 0.01% |
| Nov. 18, 2025 | Weisblum Eric | Chief Executive Officer | P | Common Stock | 7500 | $0.40 | 205,432.0000 | 9,331,346 | 3.79% | 0.08% |
| Nov. 19, 2025 | Weisblum Eric | Chief Executive Officer | P | Common Stock | 4500 | $0.41 | 209,932.0000 | 9,331,346 | 2.19% | 0.05% |
| May 27, 2025 | Weisblum Eric | Chief Executive Officer | P | Common Stock | 10000 | $0.43 | 197,932.0000 | 4,484,456 | 5.32% | 0.22% |
| May 23, 2025 | Pavell Jeff | Director | A | Options (right to buy) | 50000 | $0.00 | 50,000.0000 | 4,484,456 | 9999.99% | 1.12% |
| May 23, 2025 | Linsley Wayne | Director | A | Options (right to buy) | 50000 | $0.00 | 53,425.0000 | 4,484,456 | 1459.85% | 1.12% |
| May 23, 2025 | Munoz Kevin | Director | A | Options (right to buy) | 50000 | $0.00 | 53,425.0000 | 4,484,456 | 1459.85% | 1.12% |
| May 23, 2025 | Ryweck Daniel E. | Chief Financial Officer | A | Options (right to buy) | 50000 | $0.00 | 55,000.0000 | 4,484,456 | 1000.00% | 1.12% |
| May 23, 2025 | Weisblum Eric | Chief Executive Officer | A | Options (right to buy) | 200000 | $0.00 | 387,932.0000 | 4,484,456 | 106.42% | 4.46% |
| Dec. 13, 2024 | Weisblum Eric | CEO and President | P | Common Stock | 2500 | $0.84 | 187,932.0000 | 4,301,847 | 1.35% | 0.06% |
| Nov. 20, 2024 | Weisblum Eric | CEO and President | P | Common Stock | 2500 | $0.95 | 182,932.0000 | 4,301,847 | 1.39% | 0.06% |
| Nov. 22, 2024 | Weisblum Eric | CEO and President | P | Common Stock | 2500 | $0.90 | 185,432.0000 | 4,301,847 | 1.37% | 0.06% |
| June 12, 2024 | Weisblum Eric | CEO and President | P | Common Stock | 4438 | $1.11 | 180,432.0000 | 2,866,934 | 2.52% | 0.15% |
| June 11, 2024 | Weisblum Eric | CEO and President | P | Common Stock | 562 | $1.08 | 175,994.0000 | 2,866,934 | 0.32% | 0.02% |
| April 5, 2024 | Weisblum Eric | CEO and President | P | Common Stock | 400 | $2.03 | 175,432.0000 | 2,866,934 | 0.23% | 0.01% |
| April 4, 2024 | Weisblum Eric | CEO and President | P | Common Stock | 600 | $1.96 | 175,032.0000 | 2,866,934 | 0.34% | 0.02% |
| April 1, 2024 | Weisblum Eric | CEO and President | P | Common Stock | 1100 | $1.91 | 174,432.0000 | 2,866,934 | 0.63% | 0.04% |
| March 28, 2024 | Weisblum Eric | CEO and President | P | Common Stock | 3408 | $1.94 | 173,332.0000 | 3,079,874 | 2.01% | 0.11% |